ARTICLE I SUMMARY OF BASIC SUBLEASE PROVISIONSSublease • December 6th, 2004 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 6th, 2004 Company Industry Jurisdiction
INDEMNIFICATION AGREEMENTIndemnification Agreement • December 6th, 2004 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 6th, 2004 Company Industry JurisdictionAGREEMENT, made this day of , 2004, between Threshold Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Indemnitee”).
CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. AgreementConfidentiality Agreement • December 6th, 2004 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 6th, 2004 Company Industry JurisdictionAziende Chimiche Riunite Angelini Francesco – Acraf S.p.a., having its registered office in Viale Amelia, 70—00181 Rome Italy c.f.01312320680, p.Iva 049290810000 a company incorporated under the laws of Italy (hereinafter referred to as “Acraf”)
CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TRATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONSDevelopment Agreement • December 6th, 2004 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 6th, 2004 Company Industry JurisdictionTHIS AGREEMENT is entered into as of the 30th day of November, 2004, (“Effective Date”) by and between THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 951 Gateway Blvd., Suite 3A, South San Francisco, CA 94080, U.S.A. (“Threshold”), and MEDIBIC CO., LTD., a Japan corporation, having its head office at Daido Seimei Kasumigaseki Building 8F, 1-4-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 Japan (“MediBIC”).
CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS AGREEMENT between THRESHOLD PHARMACEUTICALS INC. and BAXTER INTERNATIONAL...Licensing Agreement • December 6th, 2004 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 6th, 2004 Company Industry JurisdictionTHRESHOLD Pharmaceuticals Inc., a corporation organized and existing under the laws of Delaware of the United States of America and having its head office at 951 Gateway Boulevard, Suite 3A, South San Francisco, CA 94080, United States of America (hereinafter referred to as “THRESHOLD”),